: According to these authors from the Italian Medicines Agency, “evidence-informed prescribing and clinical trials were beaten off the mark by social media, rumors, and panic in the early phase of the COVID-19 pandemic.” In this article, they describe lessons learned to counteract misleading information and nudge the research community to do high-quality, informative multigroup trials.
Promoting better clinical trials and drug information as public health interventions for the covid-19 emergency in italy
Genazzani A.;
2020-01-01
Abstract
: According to these authors from the Italian Medicines Agency, “evidence-informed prescribing and clinical trials were beaten off the mark by social media, rumors, and panic in the early phase of the COVID-19 pandemic.” In this article, they describe lessons learned to counteract misleading information and nudge the research community to do high-quality, informative multigroup trials.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
addis-et-al-2020-promoting-better-clinical-trials-and-drug-information-as-public-health-interventions-for-the-covid-19.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
44.93 kB
Formato
Adobe PDF
|
44.93 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
